tisagenlecleucel
novartis
['elara', 'lymsm', 'lymphoma', 'tisagenlecleucel']
an update of the elara trail (tisagenlecleucel in r/r fl): median dor, pfs, and os not reached &gt;2 years follow-up #ash2022 #lymphoma #lymsm 
Research Fellow @MSKCancerCenter Hematologist @hospitalclinic #Lymphoma #CLL.